Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and Mother-child Relationships (BBBox)

Pilot Study Evaluating the Impact of the BB Box System on Postpartum Maternal Anxiety, Post Traumatic Stress and the Establishment of a Mother-child Relationship in the Context of a Premature Birth

The main objective of this study is to compare the degree of maternal anxiety at Day 3 postpartum in mothers who did or did not have access to a video communication system (BB-Box system) from the time of initial separation with their baby.

Study Overview

Detailed Description

The secondary objectives of the study are to compare the following between the two arms of the study:

A. The degree of postpartum maternal anxiety at day 1, day 7 and at hospital discharge. Anxiety will be compared point by point but also via kinetics.

B. The incidence maternal post traumatic stress disorder at 6 and 12 months.

C. The incidence of mother-child relationship disorders at 6 and 12 months.

D. Infant vital signs during the hospital stay.

Study Type

Interventional

Enrollment (Actual)

59

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nîmes Cedex 09, France, 30029
        • CHU de Nimes - Hopital Universitaire Caremeau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is available for 12 months of follow up
  • The patient has given birth this day to a premature child (< 36 weeks of gestation and/or < 2 kg birthweight)
  • Separation of child and mother since birth

Exclusion Criteria:

  • The patient or baby is participating in another study, excepting the studies "OASIS" or "PROM8736"
  • The patient or baby is in an exclusion period determined by a previous study
  • The patient is under judicial protection, under tutorship or curatorship
  • The patient or father refuses to sign the consent
  • It is impossible to correctly inform the patient
  • Preexisting maternal psychiatric pathology
  • Major or lethal poly-malformation syndrome
  • Severe pathologies that threaten child survival: pulmonary hypertension, septic shock, anoxic-ischemic brain
  • Any emergency situation preventing patient involvement
  • Mother and/or child not hospitalized at the Nîmes University Hospital
  • Death of the patient or child during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: With BB Box
The mothers in this arm of the study will have access to a "BB Box" video system to maintain contact with their premature baby.
The BB Box video system is provided to the mother during the hospitalisation of her premature baby.
Active Comparator: Without BB Box
The mothers in this arm of the study will not have access to a "BB Box" video system to maintain contact with their premature baby. (Standard care)
The BB Box video system is not provided to the mother during the hospitalisation of her premature baby.
Other Names:
  • Standard care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire HADS
Time Frame: Day 3 post-partum
Score ranging from 0 - 21
Day 3 post-partum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire HADS
Time Frame: baseline; day 0
score ranging from 0 to 21
baseline; day 0
Questionnaire HADS
Time Frame: Day 1 post partum
score ranging from 0 to 21
Day 1 post partum
Questionnaire HADS
Time Frame: Day 7 post partum
score ranging from 0 to 21
Day 7 post partum
Questionnaire HADS
Time Frame: Day of hospital discharge for the baby (expected average of 4 weeks)
score ranging from 0 to 21
Day of hospital discharge for the baby (expected average of 4 weeks)
Questionnaire PPQ (post traumatic stress disorder)
Time Frame: 6 months post partum
score ranging from 0 to 14
6 months post partum
Questionnaire PPQ (post traumatic stress disorder)
Time Frame: 12 months post partum
score ranging from 0 to 14
12 months post partum
Massie Campbell scale for mother-child relationships
Time Frame: Day of hospital discharge for the baby (expected average of 4 weeks)
Day of hospital discharge for the baby (expected average of 4 weeks)
Massie Campbell scale for mother-child relationships
Time Frame: 6 months post partum
6 months post partum
Massie Campbell scale for mother-child relationships
Time Frame: 12 months post partum
12 months post partum
Number of infant cardiovascular events
Time Frame: base line to day of hospital discharge for the baby (expected average of 4 weeks)
includes bradycardia < 100/min and O2 saturation < 60%
base line to day of hospital discharge for the baby (expected average of 4 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fernando Benito-Castro, MD, Centre Hospitalier Universitaire de Nīmes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

January 1, 2014

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

March 27, 2012

First Submitted That Met QC Criteria

March 28, 2012

First Posted (Estimate)

March 29, 2012

Study Record Updates

Last Update Posted (Estimate)

April 30, 2015

Last Update Submitted That Met QC Criteria

April 29, 2015

Last Verified

April 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • LOCAL/2011/FBC-01
  • 2012-A00327-36 (Other Identifier: RCB number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Disorders, Post-Traumatic

Clinical Trials on BB Box available

Subscribe